SuperworthVivoSim Labs, INC. revenue VIVS
Sales by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $112K
- Latest quarter, Q1 FY27
- $18K
- −51% on a year earlier
- Fiscal year 2026
- $131K
- −9% on the year before
VivoSim Labs, INC.'s revenue was $112K over the twelve months to Jun 30, 2026, down 21% on a year earlier.
In its latest quarter, Q1 FY27, it was $18K, down 51% on the same quarter a year before.
Revenue over time
Fiscal year by fiscal year
| Fiscal year | Revenue | Change |
|---|---|---|
| FY2026 | $131K | −9% |
| FY2025 | $144K | +32% |
| FY2024 | $109K | −71% |
| FY2023 | $370K | n/a |
| FY2022 | n/a | n/a |
| FY2021 | $0 | −100% |
| FY2019 | $3.1M | −33% |
| FY2018 | $4.6M | +9% |
| FY2017 | $4.2M | +185% |
| FY2016 | $1.5M | +160% |
| FY2015 | $571K | +51% |
| FY2014 | $379K | −68% |
| FY2012 | $1.2M | +98% |
| FY2011 | $606.1K | n/a |
| FY2010 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Revenue | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | $18K | −51% | $112K | |
| Q4 FY26 | $40K | −22% | $131K | |
| Q3 FY26 | $26K | +8% | $142K | |
| Q2 FY26 | $28K | −7% | $140K | |
| Q1 FY26 | $37K | −5% | $142K | |
| Q4 FY25 | $51K | +76% | $144K | |
| Q3 FY25 | $24K | +380% | $122K | |
| Q2 FY25 | $30K | n/a | $103K | |
| Q1 FY25 | $39K | −48% | $73K | |
| Q4 FY24 | $29K | −82% | $109K | |
| Q3 FY24 | $5K | −96% | $242K | |
| Q2 FY24 | $0 | −100% | $368K |
Against its peers
Companies in Healthcare nearest VivoSim Labs, INC.'s size, closest first, today.
| Company | Revenue, 12 months | Growth |
|---|---|---|
| VIVSVivoSim Labs, INC. | $112K | −21% a year |
| OXBROXBRIDGE RE HOLDINGS | $2.8M | +40% a year |
| EDUCEducational Development | $20M | −32% a year |
| GTIMGood Times Restaurants | $135.1M | −6% a year |
| MDRRMedalist Diversified | $9.6M | −1% a year |
| BCGBinah Capital | $191.9M | +8% a year |
| VIPVulcan Infrastructure & Power | $50.9M | −14% a year |
| MXCMexco Energy | $6.7M | −9% a year |
| CKXCKX Lands | $693.4K | −17% a year |
| Peer median | $14.8M |
What the revenue tells you
Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.
Growing revenue with shrinking margins is a warning, not a win.
More on VivoSim Labs, INC.
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.